Proteor SAS
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Proteor SAS - overview
Established
1913
Location
Saint-Apollinaire, -, France
Primary Industry
Medical Devices & Equipment
About
Proteor SAS is a French company specializing in the design and manufacturing of custom orthopedic devices, enhancing the quality of life for patients with diverse health challenges. Founded in 1913 in Saint-Apollinaire, France, Proteor SAS focuses on providing orthopedic solutions. The company operates as an independent entity and has not undergone major pivots in its business strategy. The current CEOs are Matthew Swiggum and Petr Soukup.
In January 2021, a consortium led by Ardian, along with BNP Paribas Développement, acquired a minority stake in the company. Proteor specializes in the design and manufacturing of custom orthopedic devices, including prostheses and orthoses tailored for various health conditions such as scoliosis and knee osteoarthritis. The company serves a diverse clientele, including healthcare professionals and rehabilitation centers across international markets like France, Germany, Japan, the United States, and Morocco. For the year 2022, Proteor generated revenue of USD 94.
07 mn, with an EBITDA of USD 6. 42 mn, primarily through the sale of its orthopedic devices and components in B2B partnerships. Proteor plans to expand its product line with new orthopedic devices tailored for specific conditions, targeting a launch in the coming years. The company aims to increase its presence in international markets, particularly in Europe and Asia, by 2025.
The recent investment in January 2021 will support these initiatives, enhancing product development and market expansion efforts.
Current Investors
Ardian, BNP Paribas Developpement
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.proteor.fr
Verticals
E-commerce, Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Proteor SAS - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Filament Innovations | - | ||||||||
| Buyout | Completed | Proteor SAS | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.